Abstract
This paper presents preliminary summary results from a longitudinal study of participants in seven U.S. states during the COVID-19 pandemic. In addition to standard socio-economic characteristics, we collect data on various economic preference parameters: time, risk, and social preferences, and risk perception biases. We pay special attention to predictors that are both important drivers of social distancing and are potentially malleable and susceptible to policy levers. We note three important findings: (1) demographic characteristics exert the largest influence on social distancing measures and mask-wearing, (2) we show that individual risk perception and cognitive biases exert a critical role in influencing the decision to adopt social distancing measures, (3) we identify important demographic groups that are most susceptible to changing their social distancing behaviors. These findings can help inform the design of policy interventions regarding targeting specific demographic groups, which can help reduce the transmission speed of the COVID-19 virus. (JEL I11, I12, I18, D81, D91, D62, D64)
- COVID-19
- social distancing
- masks
- mask-wearing
- health markets
- health economics
- cognitive biases
- exponential growth
- behavioral economics
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was made possible thanks to grants from The State University of New York Research Seed Grant Program, Binghamton University's SSEL, and the Health Sciences and Sustainable Communities Transdisciplinary Areas of Excellence.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB Board of Binghamton University: https://www.binghamton.edu/research/compliance/humansubjects/index.html
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We thank Ariunzaya Oktyabri, Alan Adelman, Ancilla Inocencio, Xu Wang, Sharon Itin, Dylan Saez, and Hannah Werner for outstanding research support. We thank Jacob Hanna, Andrea Youngken, Jefferey Yan, Anthony DeMaria, Farris Bienstock, and Zachary Pinto for assisting with the data collection process. We thank Zoe McLaren, Lulu Garcia-Navarro, Hanna Tesfasyone, Matthew Bonci, Robin Schilling, Susan Wolcott, Nusrat Jimi, Agnitra Roy Choudhury, and Leila Salarpour for constructive feedback and helpful comments. This research was made possible thanks to grants from The State University of New York Research Seed Grant Program, Binghamton University’s SSEL, and the Health Sciences and Sustainable Communities Transdisciplinary Areas of Excellence. We gratefully acknowledge their support. All errors are our own, please let us know about them.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.